5 mg Linagliptin & 10 mg Dapagliflozin '''''

Linagliptin 5 mg & Dapagliflozin 10 mg
LINALIGLIP DAPA 5-10  
Linagliptin is a medication classified as a dipeptidyl peptidase-4 (DPP-4) inhibitor.
It works by blocking the action of the DPP-4 enzyme, which breaks down incretin hormones like GLP-1 (glucagon-like peptide-1). These hormones help regulate blood sugar levels by stimulating insulin release and reducing the production of glucose by the liver.
Linagliptin is typically taken orally as a tablet and is used to lower blood sugar levels in people with type 2 diabetes.
Dapagliflozin is a medication classified as a sodium-glucose cotransporter-2 (SGLT-2) inhibitor.
It works by inhibiting SGLT-2, a protein responsible for reabsorbing glucose in the kidneys. By blocking this protein, dapagliflozin helps the kidneys excrete excess glucose from the body through urine, thereby lowering blood sugar levels.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/linaliglip-dapa-5-10-134320